Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:52:24.277Z.
Calculation as of: 2026-10-06T15:52:24.277Z.
Quote observation: 2026-10-06T15:50:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869efbf6e11e98c8b36b953a9b631e7639c239a9e2012f11ad9cca4b0e6b7a7d
PEG RATIO
N/A
Market Cap
$676.98M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $646.58M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $643.89M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $639.06M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $631.67M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $669.48M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $676.98M | N/A | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $610.48M | N/A | 4.91 | 4.34 | 3.76 |
| Helus Pharma Inc. (HELP)vs › | $684.30M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $687.57M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.66M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
